Contact this trialFirst, we need to learn more about you.
GLP-1 Receptor Agonist
Retatrutide for Type 2 Diabetes
Recruiting1 awardPhase 3
Scottsdale, Arizona
This trial aims to see if retatrutide is better than a placebo for treating Type 2 Diabetes in patients with poor blood sugar control. It will last around 11 months and participants may need
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.